These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 30990239)

  • 1. The SILVER study. Efficacy of topical nitric-zinc complex solution in the treatment of resistant warts: A postmarketing evaluation.
    Puviani M; Manfredini M; Eisendle K
    Dermatol Ther; 2019 Jul; 32(4):e12940. PubMed ID: 30990239
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy and tolerability of nitric-zinc complex in the treatment of external genital warts and "difficult-to-treat" warts: a "proof of concept", prospective, multicentre, open study.
    Cusini M; Micali G; Lacarrubba F; Puviani M; Barcella A; Milani M
    G Ital Dermatol Venereol; 2015 Dec; 150(6):643-8. PubMed ID: 26513041
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cryotherapy versus topical nitric-zinc complex solution for the treatment of plantar warts: A randomized controlled trial.
    García-Oreja S; Álvaro-Afonso FJ; García-Madrid M; López-Moral M; García-Álvarez Y; Lázaro-Martínez JL
    J Med Virol; 2023 Nov; 95(11):e29212. PubMed ID: 37930111
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy and tolerability of a new topical nitric-zinc preparation for "difficult-to-treat" warts.
    Janniger CK; Schwartz RA
    Dermatol Ther; 2017 Mar; 30(2):. PubMed ID: 27917575
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Multicentre, Randomised Clinical Trial to Compare a Topical Nitrizinc
    Pontini P; Mastorino L; Gaspari V; Granger C; Ramoni S; Delmonte S; Evangelista V; Cusini M
    Dermatol Ther (Heidelb); 2020 Oct; 10(5):1063-1073. PubMed ID: 32734366
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Use of Topical Nitric-Zinc Complex Solution to Treat Palmoplantar and Periungual Warts in a Pediatric Population.
    Giacaman A; Granger C; Aladren S; Bauzá A; Alomar Torrens B; Riutort Mercant M; Martin-Santiago A
    Dermatol Ther (Heidelb); 2019 Dec; 9(4):755-760. PubMed ID: 31586309
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Successful treatment of periungual warts with topical cidofovir.
    Padilla España L; Del Boz J; Fernández Morano T; Arenas-Villafranca J; de Troya M
    Dermatol Ther; 2014; 27(6):337-42. PubMed ID: 25081902
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Refractory warts successfully treated with a nitric-zinc complex solution.
    Rozas-Muñoz E; Mir-Bonafé J; Piquero-Casals J
    J Dermatol; 2019 Jul; 46(7):e250-e251. PubMed ID: 30758872
    [No Abstract]   [Full Text] [Related]  

  • 9. Assessment of the efficacy of a new formulation for plantar wart mummification: new experimental design and human papillomavirus identification.
    Viennet C; Gheit T; Muret P; Aubin F; Cabou J; Marchal A; Tommasino M; Humbert P
    Clin Exp Dermatol; 2013 Jan; 38(1):85-8. PubMed ID: 23252755
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative study of topical 80% trichloroacetic acid with 35% trichloroacetic acid in the treatment of the common wart.
    Pezeshkpoor F; Banihashemi M; Yazdanpanah MJ; Yousefzadeh H; Sharghi M; Hoseinzadeh H
    J Drugs Dermatol; 2012 Nov; 11(11):e66-9. PubMed ID: 23135096
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Topical Polyphenon E in the treatment of external genital and perianal warts: a randomized controlled trial.
    Stockfleth E; Beti H; Orasan R; Grigorian F; Mescheder A; Tawfik H; Thielert C
    Br J Dermatol; 2008 Jun; 158(6):1329-38. PubMed ID: 18363746
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A randomized controlled proof-of-concept trial of digoxin and furosemide in adults with cutaneous warts.
    Rijsbergen M; Niemeyer-van der Kolk T; Hogendoorn G; Kouwenhoven S; Lemoine C; Klaassen ES; de Koning M; Beck S; Bouwes Bavinck JN; Feiss G; Burggraaf J; Rissmann R
    Br J Dermatol; 2019 May; 180(5):1058-1068. PubMed ID: 30580460
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HPV type in plantar warts influences natural course and treatment response: secondary analysis of a randomised controlled trial.
    Bruggink SC; Gussekloo J; de Koning MN; Feltkamp MC; Bavinck JN; Quint WG; Assendelft WJ; Eekhof JA
    J Clin Virol; 2013 Jul; 57(3):227-32. PubMed ID: 23518443
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human papillomavirus infection: protocol for a randomised controlled trial of imiquimod cream (5%) versus podophyllotoxin cream (0.15%), in combination with quadrivalent human papillomavirus or control vaccination in the treatment and prevention of recurrence of anogenital warts (HIPvac trial).
    Murray ML; Meadows J; Doré CJ; Copas AJ; Haddow LJ; Lacey C; Jit M; Soldan K; Bennett K; Tetlow M; Nathan M; Gilson R
    BMC Med Res Methodol; 2018 Nov; 18(1):125. PubMed ID: 30400777
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Topical zinc sulphate solution for treatment of viral warts.
    Sharquie KE; Khorsheed AA; Al-Nuaimy AA
    Saudi Med J; 2007 Sep; 28(9):1418-21. PubMed ID: 17768472
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cantharidin-Podophyllin-Salicylic Acid Formulation as a First-Line Treatment for Plantar Warts? A Case Report with Multiple Plantar Warts of Human Papillomavirus Biotype 27 and Previous Failed Treatments.
    Navarro-Pérez D; García-Oreja S; Álvaro-Afonso FJ; López-Moral M; García-Madrid M; Lázaro-Martínez JL
    Am J Case Rep; 2022 Nov; 23():e937867. PubMed ID: 36348614
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Imiquimod 5% cream for external genital or perianal warts in human immunodeficiency virus-positive patients treated with highly active antiretroviral therapy: an open-label, noncomparative study.
    Saiag P; Bauhofer A; Bouscarat F; Aquilina C; Ortonne JP; Dupin N; Mougin C
    Br J Dermatol; 2009 Oct; 161(4):904-9. PubMed ID: 19466962
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hydrogen Peroxide Topical Solution, 45% for Common Warts: Phase 2 Efficacy and Safety Trial Results.
    Smith SR; Tyring SK; Grande KK; Schlessinger J; Gold MH; Shanier SD
    J Drugs Dermatol; 2020 Oct; 19(10):969-976. PubMed ID: 33026766
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Topical zinc oxide vs. salicylic acid-lactic acid combination in the treatment of warts.
    Khattar JA; Musharrafieh UM; Tamim H; Hamadeh GN
    Int J Dermatol; 2007 Apr; 46(4):427-30. PubMed ID: 17442091
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Safety and Plasma Concentrations of a Cyclin-dependent Kinase 9 (CDK9) Inhibitor, FIT039, Administered by a Single Adhesive Skin Patch Applied on Normal Skin and Cutaneous Warts.
    Sumi E; Nomura T; Asada R; Uozumi R; Tada H; Amino Y; Sawada T; Yonezawa A; Hagiwara M; Kabashima K
    Clin Drug Investig; 2019 Jan; 39(1):55-61. PubMed ID: 30284700
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.